AnalystsSteven MahSteven Mah's Stock Forecasts
AnalystsSteven Mah
Analyst Ranking
Bottom 1%
#3842 out of 3861 analysts
Average Return
-34.38%
Win Rate
6%1 out of 16
Risk vs Reward
Poor
Good
Steven Mah's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Codexis IncCDXS | +28.04% | $6.67 | $8.54 | 2022-07-15 - 2022-08-16 | Buy |
Steven Mah's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Absci CorpABSI | 1 | Buy | N/A | N/A | Upgrades | 6 days ago |
Codexis IncCDXS | 2 | Buy | $21.00 | +145.90% | Maintains | a month ago |
Ginkgo Bioworks Holdings IncDNA | 1 | Buy | $12.00 | +220.86% | Initiates Coverage On | 6 months ago |
Talis Biomedical CorpTLIS | 2 | Hold | $9.00 | N/A | Downgrades | a year ago |
Heska CorpHSKA | 2 | Strong Buy | $305.00 | N/A | Maintains | a year ago |
Natera IncNTRA | 2 | Strong Buy | $155.00 | N/A | Maintains | a year ago |
Akoya Biosciences IncAKYA | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | a year ago |
Luminex CorpLMNX | 1 | Hold | $37.00 | N/A | Downgrades | a year ago |
Twist Bioscience CorpTWST | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | a year ago |
Fulgent Genetics IncFLGT | 1 | Strong Buy | $140.00 | N/A | Maintains | a year ago |
Ortho Clinical Diagnostics Holdings PLCOCDX | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | a year ago |
Pacific Biosciences Of California IncPACB | 1 | Strong Buy | $52.00 | N/A | Upgrades | 2 years ago |
Oxford Immunotec Global PLCOXFD | 1 | Hold | $22.00 | N/A | Downgrades | 2 years ago |
Oncocyte CorpOCX | 1 | Strong Buy | $4.00 | N/A | Upgrades | 2 years ago |
Illumina IncILMN | 1 | Hold | $340.00 | N/A | Downgrades | 2 years ago |
Quidelortho CorpQDEL | 1 | Strong Buy | $250.00 | N/A | Maintains | 2 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.